View on PubMed [PubMed] Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of New Gene Data (Int J Mol Sci, 2018) Review by Pickart and Margolina analyzing GHK-Cu's gene expression effects using large-scale gene data
How employers can manage the next phase of GLP-1 expansion Beyond 2026, GLP-1s are also being explored for their potential in other areas, such as cancer, addiction, and more, with rapidly changing dynamics
First, injectable systemic TB-500 as used in research peptide products has not completed large-scale human efficacy trials for musculoskeletal or systemic repair
First, the precision of mechanistic understanding and the complexity of translation represent the primary obstacles
Clinical trials have shown that 33.3% of participants achieved at least a 5% weight loss with 1.2 mg of ecnoglutide, compared to only 3.0% in the placebo group
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, et al